Contacts · НУХТ ↗ УКР EN
Department of
Biotechnology
and Microbiology
Apply 2026

Compatibility Research of Product Formulation Components – A Lecture from Industry Professionals

Compatibility Research of Product Formulation Components – A Lecture from Industry Professionals

At a time when on-campus classes are practically impossible due to the sounds of rockets and drones, the faculty of the BTEK Department is striving to organize the most beneficial distance learning classes whenever air raid warnings do not occur. Thus, recently for Master’s students in specialty G21 “Biotechnologies and Bioengineering,” a guest lecture on the topic “Spectroscopic Methods of Analysis in Pharmacy” was delivered by Mykhaylo Tymofiyenko (analytical chemist of the project management group at Arterium Ltd., a partner company of Arterium). And this week, during classes of the discipline “Modern Pharmaceutical Technologies,” a lecture for students was delivered by Yuriy Litvinov – Candidate of Chemical Sciences, analytical chemist of the R&D center of the pharmaceutical enterprise “Kyivmedpreparate,” which is a partner of Arterium Corporation. The topic of the lecture concerned research into the compatibility of components of medicinal products.

Yuriy Litvinov reported that at least 80% of all drugs in the world are generics. Generics are medicinal drugs that replicate the technology of the original drug after the expiration of its patent protection period. This makes the cost of developing a medicinal drug significantly lower, since it is not necessary to go through the entire product creation cycle.

It would seem that you take the active substances listed in the composition, combine them, and obtain a significantly cheaper drug. However, it is not all so simple, as our speaker explained to us. Not long ago, research published by Epstein N.O. showed that active substances present in the original formulation were found to be potentially incompatible and unstable during the creation of the copy. So what then? Usually everything depends on the technology. All factors must be taken into account: temperature, humidity, sterility, quantity, dispersion, and others. That is, it is necessary to expend resources and time to develop the technology itself. This is precisely why it is important to determine the compatibility of all components included in the composition of a medicinal drug at the stage of its development.

Furthermore, during the lecture, students examined in detail what the concept of component compatibility encompasses, as well as the consequences of combining incompatible substances, which can manifest as changes in color and appearance of the product, loss of mechanical properties of the drug, changes in solubility index, reduction in the quantitative content of the active pharmaceutical ingredient (API), and others. Examples of mutually incompatible substances were considered, including lactose and acyclovir, povidone and stearic acid. Since there are currently practically no guidelines (methodological recommendations) clarifying how to conduct compatibility research studies, Yuriy Litvinov proposed to students a unique scheme that can be used as a reference during further work in the pharmaceutical industry.

We are very grateful to the employees and partners of Arterium for such a useful and informative lecture, because in such a difficult time it is very important to receive valuable knowledge that we will be able to apply in further practical activities.

Master’s students of group FB-1-2M Mariana Krasko and Anastasia Bondarchuk